In December 2024, the Company entered into an agreement with Mayo Foundation for Medical Education and Research (Mayo), to support clinical research services to evaluate the efficacy of MN-166 (ibudi…
MediciNova, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MNOV-DEBT
Debt stack $165,198
90%
Market cache reports total debt of $165,198.
MNOV-DEBT-11034
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2012-12-31.
MediciNova, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MediciNova, Inc..
MediciNova, Inc. Ownership
Holder
Name
Confidence
Evidence
MNOV-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 30 tracked holders.
MediciNova, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.